Education
About Us
Working with TipRanks
Follow Us
Medtronic (MDT)
NYSE:MDT
MDT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$75.96 - $96.25
Previous CloseN/A
Volume4.67M
Average Volume (3M)8.13M
Market Cap
$115.85B
Enterprise Value$137.14B
Total Cash (Recent Filing)$1.24B
Total Debt (Recent Filing)$26.61B
Price to Earnings (P/E)27.5
Beta0.54
Next Earnings
May 21, 2025EPS Estimate
1.58Next Dividend Ex-Date
Mar 28, 2025Dividend Yield3.09%
Share Statistics
EPS (TTM)3.29
Shares Outstanding1,282,543,500
10 Day Avg. Volume9,411,146
30 Day Avg. Volume8,128,905
Financial Highlights & Ratios
PEG Ratio6.13
Price to Book (P/B)N/A
Price to Sales (P/S)3.49
Price to Cash Flow (P/CF)11.30
P/FCF Ratio13.20
Enterprise Value/Market Cap1.18
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit6.48
Enterprise Value/Ebitda14.60
Forecast
1Y Price Target
$96.86Price Target Upside7.23% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering18
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceMedtronic delivered a higher adjusted EPS than expected, showing strong margin and leverage capabilities.
Market PositionThe valuation of Medtronic presents an attractive entry point as shares are trading at a significant discount to US large-cap peers despite its improving growth profile.
Product PerformanceMDT's SMART trial 2-year follow-up results demonstrate that the Evolut TAVR platform continues to demonstrate superior bioprosthetic valve dysfunction (BVD) rates compared to Edwards' Sapien system in small annuli patients.
Bears Say
Revenue GrowthThe company's organic revenue growth fell short of its guidance, impacting overall performance.
Sales PerformanceMedtronic experienced a change in US distributor buying patterns, which negatively impacted its sales performance.
Segment PerformanceMedSurg fell short of expectations due to pressures in stapling and changes in US distributor purchasing patterns.
---
Ownership Overview
0.07% Insiders
25.08% Mutual Funds
19.73% Other Institutional Investors
33.86% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MDT FAQ
What was Medtronic’s price range in the past 12 months?
Medtronic lowest stock price was $75.96 and its highest was $96.25 in the past 12 months.
What is Medtronic’s market cap?
Medtronic’s market cap is $115.85B.
When is Medtronic’s upcoming earnings report date?
Medtronic’s upcoming earnings report date is May 21, 2025 which is in 57 days.
How were Medtronic’s earnings last quarter?
Medtronic released its earnings results on Feb 18, 2025. The company reported $1.39 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.03.
Is Medtronic overvalued?
According to Wall Street analysts Medtronic’s price is currently Undervalued.
Does Medtronic pay dividends?
Medtronic pays a Quarterly dividend of $0.699 which represents an annual dividend yield of 3.09%. See more information on Medtronic dividends here
What is Medtronic’s EPS estimate?
Medtronic’s EPS estimate is 1.58.
How many shares outstanding does Medtronic have?
Medtronic has 1,282,543,500 shares outstanding.
What happened to Medtronic’s price movement after its last earnings report?
Medtronic reported an EPS of $1.39 in its last earnings report, beating expectations of $1.36. Following the earnings report the stock price went down -7.262%.
Which hedge fund is a major shareholder of Medtronic?
Currently, no hedge funds are holding shares in MDT
---
Medtronic Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$96.86 (7.23% Upside)
$96.86 (7.23% Upside)
Blogger Sentiment
Bullish
MDT Sentiment 90%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 356.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 5.7%
Last 30 Days ▼ 5.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
11.07%
12-Months-Change
Fundamentals
Return on Equity
8.42%
Trailing 12-Months
Asset Growth
-0.95%
Trailing 12-Months
Company Description
Medtronic
Medtronic plc is a global leader in medical technology, services, and solutions. Headquartered in Dublin, Ireland, and operationally headquartered in Minneapolis, Minnesota, Medtronic operates in four major segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The company develops, manufactures, and markets a wide range of medical devices and technologies to treat various chronic diseases and conditions, including cardiovascular diseases, diabetes, and neurological disorders. Medtronic's mission is to alleviate pain, restore health, and extend life, serving healthcare systems, physicians, and patients in over 150 countries worldwide.
---
MDT Company Deck
---
MDT Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call was largely positive, highlighting strong revenue growth, advancements in key segments, and successful international expansion. However, some challenges in the surgical portfolio and distributor dynamics were noted.Read More>---
MDT Net sales Breakdown
36.56% Cardiovascular
29.06% Neuroscience
26.01% Medical Surgical
7.69% Diabetes
0.68% Other operating segment
---
MDT Stock 12 Month Forecast
Average Price Target
$96.86
▲(7.23% Upside)
Technical Analysis
Abbott Laboratories
―
Boston Scientific
―
Johnson & Johnson
―
Stryker
―
Zimmer Biomet Holdings
―
Best Analysts Covering MDT
1 Year
1 Year Success Rate
20/25 ratings generated profit
1 Year Average Return
+7.80%
reiterated a buy rating last month
Copying Larry Biegelsen's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +7.80% per trade.
---